Efficacy Study of Acupuncture on Spinal Compression Fracture
NCT ID: NCT01913587
Last Updated: 2021-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2013-03-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to investigate that combination with acupuncture and nerve block may relieve spinal compression fracture-related pain versus nerve block alone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupuncture & Nerve block
Acupuncture will be performed 3 times per week, total 9 sessions, during 3 weeks. Epidural nerve block and medial branch block will be performed once per week, total 3 sessions, during 3 weeks.
Acupuncture
Acupuncture points are ST36, GB34 (bilateral), BL60 (bilateral), BL40 (bilateral), and 2 Back-su points (bilateral). Back-su points are selected as close as possible to pain region. Electroacupuncture will be performed at only 2 Back-su points (bilateral).
Nerve block
Epidural nerve block uses the mixture (10ml) of dexamethasone (10 mg) and bupivacaine (10 mg) dissolved in saline solution. Medial branch block uses mepivacaine (10 mg).
Nerve block
Epidural nerve block and medial branch block will be performed once per week, total 3 sessions, during 3 weeks.
Nerve block
Epidural nerve block uses the mixture (10ml) of dexamethasone (10 mg) and bupivacaine (10 mg) dissolved in saline solution. Medial branch block uses mepivacaine (10 mg).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Acupuncture points are ST36, GB34 (bilateral), BL60 (bilateral), BL40 (bilateral), and 2 Back-su points (bilateral). Back-su points are selected as close as possible to pain region. Electroacupuncture will be performed at only 2 Back-su points (bilateral).
Nerve block
Epidural nerve block uses the mixture (10ml) of dexamethasone (10 mg) and bupivacaine (10 mg) dissolved in saline solution. Medial branch block uses mepivacaine (10 mg).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum 15% height loss of vertebrae
* Patient diagnosed with x-ray or computed tomography (CT) or magnetic resonance image (MRI)
* Visual analogue scale (VAS) score of 5 or more
* Age over 50
* 2 weeks from onset or more
* Follow-up possible during the clinical trial
* Written informed consent voluntarily
Exclusion Criteria
* Pathological fracture due to malignancy/myeloma, osteomyelitis
* Major retropulsion of bony segments into the spinal canal
* Bone metabolic disease
* Significant renal or hepatic disease
* Hypersensitive reaction to acupuncture treatment
* Senile dementia, impaired cognitive function or other cerebral disease, severe psychiatric or psychological disorders
* Alcohol/drug abuse
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daegu Catholic University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin Yong Jung
Department of anesthesiolgy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeong-Chul Seo, KMD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Comprehensive and Intergrative Medicine Institute
Min-Ah Gwak, KMD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Daegu Oriental Hospital of Daegu Haany University
Seong-Hoon Park, KMD
Role: PRINCIPAL_INVESTIGATOR
Comprehensive and Integrative Medicine Insitute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daegu Catholic University Medical Center
Daegu, Kyungsangbukdo, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIMI-13-01-21
Identifier Type: -
Identifier Source: org_study_id